Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hyperfine Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
HYPR
Nasdaq
3845
https://hyperfine.io/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hyperfine Inc
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
- Mar 21st, 2023 8:05 pm
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
- Mar 6th, 2023 1:55 pm
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
- Feb 28th, 2023 1:55 pm
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations
- Feb 21st, 2023 1:55 pm
Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System
- Feb 13th, 2023 1:55 pm
Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy
- Feb 9th, 2023 9:10 pm
Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer
- Feb 8th, 2023 9:05 pm
Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract Inclusions
- Feb 6th, 2023 11:31 pm
Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference
- Nov 22nd, 2022 9:05 pm
Hyperfine Reports Third Quarter 2022 Financial Results
- Nov 10th, 2022 9:05 pm
Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022
- Oct 27th, 2022 8:10 pm
Hyperfine Names Maria Sainz President and Chief Executive Officer
- Oct 6th, 2022 1:00 pm
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council
- Sep 7th, 2022 12:30 pm
Hyperfine to Participate in Upcoming Investor Conferences
- Aug 24th, 2022 8:10 pm
Jonathan Rothberg Is The Founder & Vice Chairman of Hyperfine, Inc. (NASDAQ:HYPR) And They Just Picked Up 24% More Shares
- Aug 15th, 2022 10:11 am
Hyperfine Reports Second Quarter 2022 Financial Results
- Aug 10th, 2022 8:05 pm
Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022
- Jul 20th, 2022 8:15 pm
Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients
- Jul 14th, 2022 1:00 pm
Hyperfine Announces CEO Transition
- Jun 29th, 2022 8:05 pm
A Hyperfine, Inc. (NASDAQ:HYPR) insider increased their holdings by 4.3% last year
- Jun 18th, 2022 12:10 pm
Scroll